In the infected groups in the 3rd week post-infection, the proportion of IgG1 increased when the mice were treated (from 41% to 50% when treated with IL-33 and to 56% and 57% when treated with anti-IL-33 and anti-ST2 mAb, respectively). The gene discussed is IL33; the disease is infection.